Further, PI-2620 controls were significantly younger than PSP-RS patients, hence age-related increase in tau-PET signal may potentially bias group comparisons between controls and PSP-RS groups, despite age adjustment of voxel-wise analyses. The gene discussed is MAPT; the disease is supranuclear palsy, progressive, 1.